There's a lot of talk about the role that generative artificial intelligence (AI) will have to play in the pharma industry, and a new alliance between Eversana and Amazon
Teva has launched a digitally-enabled inhaler in the UK, the first European market for the device, for use by patients with asthma and chronic obstructive pulmonary disord
Astellas has licensed rights to a smart stethoscope device developed by Eko Health, that it will use as part of a digital therapeutic (DTx) approach to heart failure.
US non-profit the Peterson Centre on Healthcare has launched a new institute, backed with $50 million in funding, that will take a close look at the clinical benefits and
Researchers in the US have developed an artificial intelligence (AI) algorithm that can be used to predict whether a drug has the potential to harm developing foetuses in
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.